Adeyinka Adegoke

Adeyinka Adegoke

Auto-generated profile, based on publicly available information

Adeyinka Adegoke

Department of Business Administration, Northern Alberta Institute of Technology, Edmonton, Alberta, Canada, Canada

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2026 in Health Services Insights
Verified
Journal Article
Open access
Kola AdegokeKola Adegoke
Kola Adegoke
ODOlajide Alfred Durojaye
Olajide Alfred Durojaye
AAAbimbola Adegoke
Abimbola Adegoke
AAAdeyinka Adegoke
Adeyinka Adegoke
Background: Soaring drug prices pose a significant obstacle to affordable and equitable access to medicines in high-income healthcare systems. This study compares two leading reform tool families, Most Favored Nation (MFN)/international reference pricing (IRP) and value-based contracting (VBC), across the United States, Canada, and the United Kingdom, with attention to cost containment, value-linked incentive design, equity of access, and implementation feasibility. U.S. policy developments (CMS Innovation Center’s GENEROUS, GLOBE, and GUARD models) extend international benchmark-based design options beyond the 2020 MFN rule. Methods: Guided by institutional and governance theories, we conducted a structured comparative policy analysis using a four-dimensional trade-off matrix. Cases from the United States, Canada, and the United Kingdom were selected using a most-different-systems design. Documents from 2007 to 2025 were coded for cost containment, value-linked incentive design, equity, and implementation feasibility. To reduce subjectivity, scores were assigned using prespecified rubric anchors, conservative scoring rules for borderline cases, and a sensitivity check of adjacent-score judgments. Design-stage U.S. benchmark-based model materials assessed on March 5, 2026, were incorporated descriptively and not considered as outcome evidence. Results: The United Kingdom model, centered on the National Institute for Health and Care Excellence (UK NICE) and the Voluntary Scheme for Branded Medicines Pricing, Access and Growth (VPAG), was most consistently aligned across all four dimensions (design-feature alignment). Canada’s Patented Medicine Prices Review Board (PMPRB) supports affordability and baseline access, with implementation variation across provinces and more limited adoption of outcomes-based contracting. U.S. MFN/IRP initiatives and VBC pilots show lower alignment on equity and feasibility in a multi-payer environment characterized by contested authority and variable data/contracting capacity. Emerging CMS Innovation Center proposals (GENEROUS, GLOBE, GUARD) indicate continued federal interest in benchmark-based designs, but empirical impacts remain to be evaluated. Conclusions: MFN/IRP anchoring and VBC are implementation-intensive tools whose performance depends on institutional fit. A hybrid approach, using international benchmarks as inputs for negotiations and expanding value-linked agreements where measurement and governance prerequisites are met, may offer a more feasible U.S. pathway. This study provides a repeatable framework for assessing drug pricing reforms and illustrates how institutional alignment conditions the implementability of tools. Design-feature scores reflect policy design and governance capacity, not realized outcomes.

23 January 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Kola AdegokeKola Adegoke
Kola Adegoke
ODOlajide Alfred Durojaye
Olajide Alfred Durojaye
AAAbimbola Adegoke
Abimbola Adegoke
Deborah DawoduDeborah Dawodu
Deborah Dawodu
AAAdeyinka Adegoke
Adeyinka Adegoke
EAEunice Bisola Akano
Eunice Bisola Akano
Background: U.S. hospitals have increasingly affiliated with multi-hospital chains, raising questions about whether consolidation yields operational efficiencies or primarily reflects integration costs and market power. Evidence on the dynamic financial response to chain entry—especially in recent years—remains limited.Objective: To estimate dynamic association in hospital financial margins around sustained chain joining using a staggered-adoption-robust event-study design.Methods: We analyzed a RAND-processed HCRIS hospital panel (2014–2023). Dynamic effects were estimated using the Sun & Abraham interaction-weighted event-study estimator with hospital and year fixed effects and hospital-clustered standard errors. We implemented two baseline rules (“has2014” and “entry”) and examined total, operating, and cash-flow margins. To reduce ratio outliers, margins were cleaned using year-specific denominator screening and hard caps for extreme values (|margin|>500%), then winsorized within year (p1/p99) for main analyses. Depending on outcome and baseline rule, models used approximately 13,000–24,000 hospital-year observations, covering ~2,600–2,900 hospitals and roughly 600 sustained chain joins. Robustness checks included a balanced-panel restriction, a treated-only stacked specification, placebo assignment among never-treated hospitals, and ownership-stratified estimates.Results: Lead coefficients were generally small, but cash-flow margins exhibited a statistically detectable negative lead at t = −4 in both baseline rules (p≈0.03), while other leads were typically indistinguishable from zero. Post-entry effects were modest and imprecise across outcomes. Total margins showed near-zero contemporaneous changes at t=0 and small negative estimates in years 1–3 that attenuated by year 4. Operating and cash-flow margins displayed small post-entry declines around t=2 (≈1 percentage point in magnitude; p≈0.06–0.09). Robustness checks (balanced panel, stacked design, placebo) broadly supported a null or weak-transient pattern. Ownership stratification suggested modest longer-run improvements for nonprofit hospitals in later post years (e.g., t=4: +3.7 percentage points; p=0.045), while for-profit estimates were mixed and imprecise.Conclusions: Over 2014–2023, sustained chain joining was not associated with consistent, sustained improvements in hospital financial margins on average. Observed changes were small, often imprecise, and in some outcomes suggest modest short-run declines consistent with integration costs. Continued monitoring with longer post-entry windows and additional outcomes is warranted.

2 December 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Kola AdegokeKola Adegoke
Kola Adegoke
ODOlajide Durojaye
Olajide Durojaye
AAAbimbola Adegoke
Abimbola Adegoke
AAAdeyinka Adegoke
Adeyinka Adegoke
Background: Soaring drug prices threaten affordability and equity in high-income health systems. This study examines how two families of reform tools, international reference pricing (including the U.S. Most Favored Nation–type proposals and Canada’s PMPRB comparators) and value-based payment approaches, perform across four core policy goals: cost containment, innovation, equity, and implementation feasibility.Methods: Guided by institutional and governance theories, we conducted a structured comparative policy analysis of the United States, Canada, and the United Kingdom using a four-dimensional trade-off matrix. We coded 37 documents (2007–2025), including policy guidance, legislation, and empirical evaluations, to rate each country–instrument pair (1–5) on cost, innovation incentives, equity of access, and feasibility, based on design features rather than realized outcomes.Results: The U.K.’s integrated model, combining NICE’s cost-effectiveness appraisals with the voluntary scheme for branded medicines (VPAG), shows the most consistent alignment across all four dimensions. Canada’s PMPRB-based system achieves strong cost control and broad baseline access but provides weaker, indirect innovation incentives and limited outcome-linked pricing. In the U.S., MFN-type proposals and pharmaceutical value-based contracts face legal challenges, fragmented payers, and limited infrastructure, resulting in low scores on equity and feasibility despite some innovation-supportive features.Conclusions: Neither international reference pricing nor value-based payment alone is sufficient to advance Universal Health Coverage goals. A hybrid approach, anchoring negotiations in international benchmarks while linking reimbursement to therapeutic value, appears more realistic for fragmented systems such as the U.S., but only if accompanied by investments in data, governance, and federal negotiating capacity. The trade-off matrix offers a repeatable framework for assessing pricing reforms and illustrates how institutional “fit,” rather than technical design alone, shapes policy success.

5 January 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Kola AdegokeKola Adegoke
Kola Adegoke
AAAbimbola Adegoke
Abimbola Adegoke
Deborah DawoduDeborah Dawodu
Deborah Dawodu
ABAyoola Emmanuel Bayowa
Ayoola Emmanuel Bayowa
AAAkorede Adekoya
Akorede Adekoya
AAAdeyinka Adegoke
Adeyinka Adegoke
Background: COVID-19 coincided with increased mental health needs in Alberta, Canada, intensifying pre-existing access gaps and service strain. Alberta responded with publicly funded interventions spanning digital care, youth-focused services, and recovery-oriented programs. Objective: To evaluate Alberta’s system-level response to pandemic-related increases in mental health help-seeking/service uptake using a health economics and policy lens. Methods: We extracted empirically reported program delivery outputs from the 2023–2024 Alberta Mental Health and Addiction Annual Report. We used a simulation calibrated to reported trends to examine directional changes in help-seeking (demand), service capacity (supply), and the modeled equilibrium quantity under a zero-copayment design. Results: Empirically reported outputs indicate that delivery met or exceeded planned/funded milestones for CASA Mental Health, VODP, and tele-mental health, while recovery communities reflected phased implementation. In the illustrative simulation, the demand-implied volume increases from 60 to 87 services/month, but delivered volume is capacity-constrained at 78 services/month (implying ~9 services/month unmet demand), while a unit-cost proxy is held constant for visualization (not an observed market price or patient copayment).Conclusion: Alberta’s response illustrates how coordinated, publicly funded capacity expansion and access-oriented policies can support service delivery during system shocks; the model also highlights that if capacity growth lags demand growth, unmet need may persist even under zero copayment.

25 March 2026 in PLOS Mental Health
Verified
Journal Article
Open access
Kola AdegokeKola Adegoke
Kola Adegoke
AAAbimbola Adegoke
Abimbola Adegoke
Deborah DawoduDeborah Dawodu
Deborah Dawodu
ABAyoola Emmanuel Bayowa
Ayoola Emmanuel Bayowa
AAAkorede Adekoya
Akorede Adekoya
AAAdeyinka Adegoke
Adeyinka Adegoke
COVID-19 coincided with increased mental health needs in Alberta, Canada, intensifying pre-existing access gaps and service strain. Alberta responded with publicly funded interventions spanning digital care, youth-focused services, and recovery-oriented programs. To evaluate Alberta’s system-level response to pandemic-related increases in mental health help-seeking/service uptake using a health economics and policy lens. We extracted empirically reported program delivery outputs from the 2023–2024 Alberta Mental Health and Addiction Annual Report. We used a simulation calibrated to reported trends to examine directional changes in help-seeking (demand), service capacity (supply), and the modeled equilibrium quantity under a zero-copayment design. Empirically reported outputs indicate that delivery met or exceeded planned/funded milestones for CASA Mental Health, VODP, and tele-mental health, while recovery communities reflected phased implementation. In the illustrative simulation, the demand-implied volume increases from 60 to 87 services/month, but delivered volume is capacity-constrained at 78 services/month (implying ~9 services/month unmet demand), while a unit-cost proxy is held constant for visualization (not an observed market price or patient copayment). Alberta’s response illustrates how coordinated, publicly funded capacity expansion and access-oriented policies can support service delivery during system shocks; the model also highlights that if capacity growth lags demand growth, unmet need may persist even under zero copayment.